INS and type 2 diabetes mellitus: It is crucial to establish these relationships, given that emerging adjunctive therapies proposed to improve insulin sensitivity and kidney metabolism, such as GLP-1RA and SGLT2i, which were previously shown to be strongly kidney protective in type 2 diabetes (T2D), are currently being tested in individuals with T1D (41–43).